Abu Dhabi’s state-backed health-care investment company M42 has taken a stake in biotech startup Juvenescence, a UK-based ...

Abu Dhabi's M42 has announced a partnership and investment in UK-based longevity biotech leader Juvenescence. The new ...

M42 has partnered with Toshiba Energy Systems & Solutions Corporation (Toshiba ESS) to build the Middle East’s first ...

M42, a global health champion powered by AI and technology, announced that Cleveland Clinic Abu Dhabi, part of the M42 group, ...

M42 and Juvenescence will collaborate in drug discovery to develop a pipeline of innovative medicines to advance the ...

Cleveland Clinic Abu Dhabi, part of the M42 group, has achieved a historic milestone in global healthcare. In collaboration ...

Abu Dhabi, United Arab Emirates – A groundbreaking ‘Declaration on Longevity and Precision Medicine’ was launched at Abu ...

The Abu Dhabi health care company M42 is to make an investment in U.K.-based longevity specialist Juvenescence as a route to moving into drug discovery and development, with the two forming a ...

Abu Dhabi is set to build an advanced cancer treatment center in the Middle East, marking its latest foray into the health-care sector as part of a multibillion-dollar diversification push.

The UAE's healthcare sector has reinforced its leading position since the beginning of the year through a series of rare surgical procedures and the ...

The new systems are to be developed particularly in critical areas such as oncology, rare genetic diseases, and metabolic disorders ...

Abu Dhabi is set to build an advanced cancer treatment center in the Middle East, marking its latest foray into the health care sector as part of a multibillion-dollar diversification push. M42’s ...